These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1209 related items for PubMed ID: 14664657

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
    Fulton B, Perry CM.
    Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
    Entenza JM, Caldelari I, Glauser MP, Moreillon P.
    J Antimicrob Chemother; 1999 Dec; 44(6):775-86. PubMed ID: 10590278
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Levofloxacin in the treatment of community-acquired pneumonia.
    Noreddin AM, Elkhatib WF.
    Expert Rev Anti Infect Ther; 2010 May; 8(5):505-14. PubMed ID: 20455679
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
    Zervos M, Mandell LA, Vrooman PS, Andrews CP, McIvor A, Abdulla RH, de Caprariis PJ, Knirsch CA, Amsden GW, Niederman MS, Lode H.
    Treat Respir Med; 2004 May; 3(5):329-36. PubMed ID: 15606222
    [Abstract] [Full Text] [Related]

  • 33. Gatifloxacin, an advanced 8-methoxy fluoroquinolone.
    Fish DN, North DS.
    Pharmacotherapy; 2001 Jan; 21(1):35-59. PubMed ID: 11191737
    [Abstract] [Full Text] [Related]

  • 34. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Weiss LR.
    Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
    [Abstract] [Full Text] [Related]

  • 35. The clinical pharmacokinetics of levofloxacin.
    Fish DN, Chow AT.
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [Abstract] [Full Text] [Related]

  • 36. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD, Balfour JA.
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Use of ofloxacin in infections which do not readily respond to treatment].
    Zalaudek G.
    Antibiot Khimioter; 1996 Aug; 41(9):11-2. PubMed ID: 9005779
    [Abstract] [Full Text] [Related]

  • 39. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
    Bundrick W, Heron SP, Ray P, Schiff WM, Tennenberg AM, Wiesinger BA, Wright PA, Wu SC, Zadeikis N, Kahn JB.
    Urology; 2003 Sep; 62(3):537-41. PubMed ID: 12946763
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.